ITEM#: 3042-HPA00572925UL
MFR#: HPA005729-25UL
Anti-GALT antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Product Name | Description | Item# | QTY | |
---|---|---|---|---|
Anti-GALT antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | Anti-GALT antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | 3042-HPA005729100UL | EA | |
Anti-GALT antibody produced in rabbit Ab1, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | GALT (galactose-1-phosphate uridylyltransferase) is majorly involved in the Leloir pathway of galactose metabolism. Structural studies have been reported that GALT is a homodimeric molecule. Each monomer consists of six α-helices and a β-sheet form | 3042-HPA00486825UL | EA | |
Anti-GALT antibody produced in rabbit Ab1, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | GALT (galactose-1-phosphate uridylyltransferase) is majorly involved in the Leloir pathway of galactose metabolism. Structural studies have been reported that GALT is a homodimeric molecule. Each monomer consists of six α-helices and a β-sheet form | 3042-HPA004868100UL | EA | |
Anti-GSTP1 antibody produced in rabbit Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2 | GSTP1 (Glutathione S-transferase pi 1) is a novel cyclin dependent kinase-5 regulatory protein encoding a detoxifying enzyme. It is widely expressed in normal tissues. | 3042-HPA01986925UL | EA | |
Anti-GPKOW antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | Anti-GPKOW antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | 3042-HPA00189425UL | EA | |
Anti-H6PD antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | Anti-H6PD antibody produced in rabbit Ab2, Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | 3042-HPA00544025UL | EA | |
Anti-LBHD1 antibody produced in rabbit Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2 | The gene C11orf48, also referred to as LBHD1 (LBH domain containing 1), is found to be translated in more than one reading frame (from different transcripts as well as from the same mRNA), which is also known as dual coding. The dual coding regions c | 3042-HPA02359225UL | EA | |
Anti-MAP7 antibody produced in rabbit Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2 | Anti-MAP7 antibody produced in rabbit Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2 | 3042-HPA02971325UL | EA | |
Anti-ZZEF1 antibody produced in rabbit Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2 | Anti-ZZEF1 antibody produced in rabbit Prestige Antibodies(R) Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2 | 3042-HPA03179025UL | EA |
Thank you for visiting, your account is pending approval.
You will received email notification for approval within 24hrs.
Contact customerservice@franklinyoung.com for any questions.
Thank you for requesting an account with Franklin Young.
Your request has been declined
We restrict website access to government entities, and related customers.
Please contact customerservice@franklinyoung.com with any questions.